Straumann Holding AGFRA:QS50 +2.78%99 Operating Margin % is 17.47% as of Dec. 2025, which is 28% below its 10-year median of 24.25. GuruFocus rates FRA:QS50 with a GF Score™ of 99/100 and a GF Value™ of €14.38. The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Straumann Holding AG ranks better than 88.24% on this metric.
Straumann Holding AG operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Straumann Holding AG's Operating Margin % or its related term are showing as below:
FRA:QS50'
s Operating Margin % Range Over the Past 10 Years
Min: 10.64 Med: 24.25 Max: 26.53
Current: 21.08
FRA:QS50's Operating Margin % is ranked better than 88.24% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs FRA:QS50: 21.08
Straumann Holding AG's 5-Year Average Operating Margin % Growth Rate was 9.70% per year.
Straumann Holding AG (FRA:QS50) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Straumann Holding AG Operating Margin % Related Terms
Straumann Holding AG Operating Margin % Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:QS50 vs ISRG, BDX, MDLN: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Operating Margin % falls into.
Straumann Holding AG Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Straumann Holding AG's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (FRA:QS50) has a Operating Margin % of 17.47% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Straumann Holding AG and its competitors. This is 28% below median its historical median of 24.25. Over the past decade, Straumann Holding AG's Operating Margin % has ranged from 10.64 to 26.53. According to the industry distribution chart, Straumann Holding AG ranks #96 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 11.8%.
Is Straumann Holding AG's Operating Margin % too high?
Straumann Holding AG's current Operating Margin % of 17.47% is 28% below median its 10-year median of 24.25. Over the past 10 years, this metric has ranged from a low of 10.64 to a high of 26.53. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Straumann Holding AG's value of 17.47% is 404.2% above this industry median. Based on the distribution chart, Straumann Holding AG ranks #96 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Straumann Holding AG has a GF Score™ of 99/100, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #96 out of 816 companies for Operating Margin %. This places Straumann Holding AG in the top 12% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. Straumann Holding AG's value of 17.47% is 404.2% above this benchmark. Historically, Straumann Holding AG's own Operating Margin % has ranged from 10.64 to 26.53 over the past decade. While the company's 10-year median is 24.25 vs. the industry median of 3.47, Straumann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current Operating Margin % of 17.47% is 404.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Operating Margin % is 17.47%, which is 28% below median its own 10-year median of 24.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Straumann Holding AG (FRA:QS50) has a current Operating Margin % of 17.47%. The stock's GF Value™ is €14.38, compared to a current price of €11.10 — trading 22.8% below its estimated fair value. The current Operating Margin % is 17.47%, which is 28% below median its 10-year median of 24.25 and 404.2% above the Medical Devices & Instruments industry median of 3.47. Straumann Holding AG's overall GF Score™ is 99/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Straumann Holding AG (FRA:QS50), the current Operating Margin % is 17.47% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (FRA:QS50) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of €11.10 is trading 22.8% below its estimated GF Value™ of €14.38.
Key valuation signals for FRA:QS50:
Operating Margin %: 17.47% (28% below median its 10-year median of 24.25)
GF Value™: €14.38 vs. price of €11.10 (22.8% below fair value)
Industry Position: 404.2% above the Medical Devices & Instruments median (#96 of 816)
No single metric tells the full story. See the FRA:QS50 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
99GF Score
Get the complete analysis for FRA:QS50
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:QS50 has been successfully added to your 
